NDC 79903-032-01 - EXTRA STRENGTH ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 79903-032
- Requested NDC
- 79903-032-01
- Package NDCs from labels
- 79903-032-01, 79903-032-02, 79903-032-40, 79903-032-10
- Manufacturer
- Wal-Mart Stores Inc
- Effective date
- 2026-01-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| EXTRA STRENGTH ACETAMINOPHEN - Wal-Mart Stores Inc | Wal-Mart Stores Inc | 2026-01-27 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 79903-032-01 | EXTRA STRENGTH ACETAMINOPHEN | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 79903-032-02 | EXTRA STRENGTH ACETAMINOPHEN | 2 in 1 CARTON | TABLET | 2 | 9 | |
| 79903-032-10 | EXTRA STRENGTH ACETAMINOPHEN | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 79903-032-40 | EXTRA STRENGTH ACETAMINOPHEN | 1 in 1 CARTON | TABLET | 1 | 9 | |
| 79903-032-40 | EXTRA STRENGTH ACETAMINOPHEN | 40 in 1 BOTTLE | TABLET | 40 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 79903-032-02 | EA - Each | 79903-032 | a10a10d5-5af2-4301-8812-8416ef5a93c1 | 1 | 2023-09-05 |
| 79903-032-10 | EA - Each | 79903-032 | efb4f630-797b-4a17-94d1-02abfd986a35 | 1 | 2022-12-07 |
| 79903-032-40 | EA - Each | 79903-032 | 4422bb8e-0e56-4f3a-af3e-a7762b7f0050 | 1 | 2022-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SUNSCREEN SPF50 | ETHYLHEXYL METHOXYCINNAMATE, OCTOCRYLENE, TITANIUM DIOXIDE | Guangzhou Tinsun Biotechnology Company Limited | 3bc1c6e9-1dd5-d7c6-e063-6394a90ad89e | 2025-08-07 | Warnings | 15FIX9V2JP |
| Low Dose Aspirin | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION INC | c46688ec-e976-4f76-9265-645f59970ff5 | 2025-08-06 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | P & L Development, LLC | c54ad829-f2e8-4367-b439-af20b0ef8ad2 | 2025-08-06 | Warnings | M013 362O9ITL9D |
| TYLENOL Regular Strength | ACETAMINOPHEN | Kenvue Brands LLC | 398d8996-b522-a3cd-e063-6394a90ac2c8 | 2025-08-06 | Warnings | M013 362O9ITL9D |
| Dolce and Gabbana Everlast Foundation SPF 20 17W Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 053cb3cd-dd16-4d08-b347-a4349fa37c07 | 2025-08-06 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 14W Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 7bf90657-b636-41d6-b96c-88d174989f5b | 2025-08-06 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 15N Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | da7e19cd-6a8b-47df-bfc9-2f0f11b7955c | 2025-08-06 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 16N Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f7a1d379-6de0-4be4-84a9-e0ebef332bef | 2025-08-06 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 18N Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 671be8a6-51b7-45d2-9fff-c7736d2eea3e | 2025-08-06 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 19W Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 9efa5db5-d774-4089-895c-9667eda0f11b | 2025-08-06 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 20C Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 76232666-e23f-4842-bd0d-37819739ec3a | 2025-08-06 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 21W Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 876b9a5d-dae3-47f1-9da6-b5e179fd28cd | 2025-08-06 | Warnings | 15FIX9V2JP |
| UV SOLUTIONS BRIGHTENING TINTED BROAD SPECTRUM SPF 50 SUNSCREEN NIACINAMIDE ANTIOXIDANTS | TITANIUM DIOXIDE AND ZINC OXIDE | CLINIQUE LABORATORIES LLC | 3bba70e9-da29-f43b-e063-6294a90a08ef | 2025-08-06 | Warnings | 15FIX9V2JP |
| NAKED SUNDAYS CABANA GLOW MINERAL GLOW SERUM DROPS PEARL 40mL with Pink Algae SPF 50 | TITANIUM OXIDE, ZINC OXIDE | NAKED SUNDAYS PTY LTD | 0127f290-8c5e-4285-e063-6294a90ae128 | 2025-08-06 | Warnings | 15FIX9V2JP |
| GR BB SPF 25 | OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE | ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI | 3b22579b-21ce-4b96-bd24-774ce35bf6f7 | 2025-08-06 | Warnings | 15FIX9V2JP |
| Daytime Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | H E B | b7434978-44a8-4c51-979d-0bc446461e43 | 2025-08-06 | Warnings | 362O9ITL9D |
| Aspirin | ASPIRIN | Marlex Pharmaceuticals Inc. | cc7013ea-cf30-6f59-e053-2a95a90a1148 | 2025-08-05 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Prostat First Aid | 3ba313db-bafe-1947-e063-6294a90a528c | 2025-08-05 | Warnings | M013 362O9ITL9D |
| Dolce and Gabbana Everlast Foundation SPF 20 08W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 498bf941-67f2-41d5-a039-9f827b68297e | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 10N Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 54e390bd-b84a-4c43-986e-74923e34689d | 2025-08-05 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.